The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless products signifies a substantial regulatory problem with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to act as a sedative at large dosages6. The statements created by Nicot